WI, E., A, B., & M, K. (2015). Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab. Journal of neuro-oncology, 125(2), 445. https://doi.org/10.1007/s11060-015-1925-8
Chicago Style (17th ed.) CitationWI, Essayed, Bernard A, and Kalamarides M. "Clinical Response Associated with Radiographic Regression of a Cervicomedullary Ependymoma in a NF2 Patient Treated by Bevacizumab." Journal of Neuro-oncology 125, no. 2 (2015): 445. https://doi.org/10.1007/s11060-015-1925-8.
MLA (9th ed.) CitationWI, Essayed, et al. "Clinical Response Associated with Radiographic Regression of a Cervicomedullary Ependymoma in a NF2 Patient Treated by Bevacizumab." Journal of Neuro-oncology, vol. 125, no. 2, 2015, p. 445, https://doi.org/10.1007/s11060-015-1925-8.